Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (2s)-2,6-diamino-n-(4-(2-(2-(4-((2-cyanoethyl)amino)-1,2,5-oxadiazol-3-yl)-1h-benzimidazol-1-yl)acetyl)phenyl)hexanamide
2. Bal101553
1. Bal101553
2. Bal-101553
3. Lisavanbulin [inn]
4. Lisavanbulin [usan]
5. 1263384-43-5
6. 5pt0qp06x5
7. Microtubule-targeted Agent Bal101553
8. (2s)-2,6-diamino-n-(4-(2-(2-(4-((2-cyanoethyl)amino)-1,2,5-oxadiazol-3-yl)-1h-benzimidazol-1-yl)acetyl)phenyl)hexanamide
9. Hexanamide, 2,6-diamino-n-(4-(2-(2-(4-((2-cyanoethyl)amino)-1,2,5-oxadiazol-3-yl)-1h-benzimidazol-1-yl)acetyl)phenyl)-, (2s)-
10. Lisavanbulin (usan/inn)
11. Lisavanbulin [usan:inn]
12. Unii-5pt0qp06x5
13. Lisavanbulin [who-dd]
14. Schembl1160313
15. Chembl4297595
16. Glxc-25728
17. Ex-a4306
18. Nsc764608
19. Nsc789724
20. Who 10401
21. Bal 101553
22. Db15224
23. Nsc-764608
24. Nsc-789724
25. D11494
26. Q27262705
| Molecular Weight | 515.6 g/mol |
|---|---|
| Molecular Formula | C26H29N9O3 |
| XLogP3 | 1.5 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 13 |
| Exact Mass | 515.23933582 g/mol |
| Monoisotopic Mass | 515.23933582 g/mol |
| Topological Polar Surface Area | 191 Ų |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 828 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Immune Checkpoint Inhibitors
Drugs that block negative regulator IMMUNE CHECKPOINT proteins (e.g., PD-1 RECEPTOR and CTLA-4 ANTIGEN) thereby increasing suppressed immune activation in immunotherapies. (See all compounds classified as Immune Checkpoint Inhibitors.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Lisavanbulin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lisavanbulin, including repackagers and relabelers. The FDA regulates Lisavanbulin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lisavanbulin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Lisavanbulin supplier is an individual or a company that provides Lisavanbulin active pharmaceutical ingredient (API) or Lisavanbulin finished formulations upon request. The Lisavanbulin suppliers may include Lisavanbulin API manufacturers, exporters, distributors and traders.
Lisavanbulin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lisavanbulin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lisavanbulin GMP manufacturer or Lisavanbulin GMP API supplier for your needs.
A Lisavanbulin CoA (Certificate of Analysis) is a formal document that attests to Lisavanbulin's compliance with Lisavanbulin specifications and serves as a tool for batch-level quality control.
Lisavanbulin CoA mostly includes findings from lab analyses of a specific batch. For each Lisavanbulin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lisavanbulin may be tested according to a variety of international standards, such as European Pharmacopoeia (Lisavanbulin EP), Lisavanbulin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lisavanbulin USP).
LOOKING FOR A SUPPLIER?
